Summary
This report studies the Primary Biliary Cirrhosis Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Primary Biliary Cirrhosis Drug market by product type and application/end industries.
The global Primary Biliary Cirrhosis Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Primary Biliary Cirrhosis Drug.
United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.
Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Primary Biliary Cirrhosis Drug in these regions, from 2013 to 2025 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa
The major players in global and United States market, including
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Johnson & Johnson
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.
On the basis of product, the market is primarily split into
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
On the basis on the end users/application, this report covers
Clinic
Hospital
Others
Table of Contents
2018-2025 Primary Biliary Cirrhosis Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
2 Primary Biliary Cirrhosis Drug Market Overview
2.1 Primary Biliary Cirrhosis Drug Product Overview
2.2 Primary Biliary Cirrhosis Drug Market Segment by Type
2.2.1 Budesonide
2.2.2 FFP-104
2.2.3 GSK-2330672
2.2.4 MBX-8025
2.2.5 NGM-282
2.2.6 Others
2.3 Global Primary Biliary Cirrhosis Drug Product Segment by Type
2.3.1 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
2.3.2 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share (%) by Type (2013-2018)
2.3.3 Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
2.3.4 Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Type (2013-2018)
2.4 United States Primary Biliary Cirrhosis Drug Product Segment by Type
2.4.1 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
2.4.2 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share by Type (2013-2018)
2.4.3 United States Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Type (2013-2018)
2.4.4 United States Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Type (2013-2018)
3 Primary Biliary Cirrhosis Drug Application/End Users
3.1 Primary Biliary Cirrhosis Drug Segment by Application/End Users
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Primary Biliary Cirrhosis Drug Product Segment by Application
3.2.1 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.2.2 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Primary Biliary Cirrhosis Drug Product Segment by Application
3.3.1 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.3.2 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
4 Primary Biliary Cirrhosis Drug Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Primary Biliary Cirrhosis Drug Market Size and CAGR by Regions (2013, 2017 and 2025)
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Primary Biliary Cirrhosis Drug Sales and Revenue by Regions
4.2.1 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
4.2.2 Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
4.2.3 Global Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.4 North America Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.5 Europe Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.6 Asia-Pacific Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.7 South America Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
4.2.8 Middle East and Africa Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
4.2.9 United States Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
5 Global Primary Biliary Cirrhosis Drug Market Competition by Players/Manufacturers
5.1 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Primary Biliary Cirrhosis Drug Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Primary Biliary Cirrhosis Drug Manufacturing Base Distribution, Sales Area, Product Types
5.5 Primary Biliary Cirrhosis Drug Market Competitive Situation and Trends
5.5.1 Primary Biliary Cirrhosis Drug Market Concentration Rate
5.5.2 Global Primary Biliary Cirrhosis Drug Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion
6 United States Primary Biliary Cirrhosis Drug Market Competition by Players/Manufacturers
6.1 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Primary Biliary Cirrhosis Drug Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Primary Biliary Cirrhosis Drug Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Primary Biliary Cirrhosis Drug Market Share (%) of Top 3 and Top 5 Players
7 Primary Biliary Cirrhosis Drug Players/Manufacturers Profiles and Sales Data
7.1 AlbireoPharma
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.1.4 Main Business/Business Overview
7.2 CymaBay Therapeutics, Inc.
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.2.4 Main Business/Business Overview
7.3 Dr. Falk Pharma GmbH
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.3.4 Main Business/Business Overview
7.4 Enanta Pharmaceuticals, Inc.
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.4.4 Main Business/Business Overview
7.5 GlaxoSmithKline Plc
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.5.4 Main Business/Business Overview
7.6 Intercept Pharmaceuticals, Inc.
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.6.4 Main Business/Business Overview
7.7 Johnson & Johnson
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.7.4 Main Business/Business Overview
7.8 MediGene AG
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.8.4 Main Business/Business Overview
7.9 NGM Biopharmaceuticals, Inc.
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.9.4 Main Business/Business Overview
7.10 Virobay Inc.
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
7.10.4 Main Business/Business Overview
8 Primary Biliary Cirrhosis Drug Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 Primary Biliary Cirrhosis Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Primary Biliary Cirrhosis Drug Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 Marketing Strategy Analysis, Distributors and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 Global Primary Biliary Cirrhosis Drug Market Forecast
10.1 Global Primary Biliary Cirrhosis Drug Sales, Revenue Forecast (2018-2025)
10.1.1 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.1.2 Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Primary Biliary Cirrhosis Drug Market Forecast
10.2.1 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
10.2.2 United States Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Primary Biliary Cirrhosis Drug Forecast by Regions
10.3.1 North America Primary Biliary Cirrhosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.2 Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.3 Asia-Pacific Primary Biliary Cirrhosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.4 South America Primary Biliary Cirrhosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.3.5 Middle East and Africa Primary Biliary Cirrhosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Primary Biliary Cirrhosis Drug Forecast by Type
10.4.1 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.4.2 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Primary Biliary Cirrhosis Drug Forecast by Application
10.5.1 Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2018-2025)
10.5.2 United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Primary Biliary Cirrhosis Drug Product Picture
Figure Global Primary Biliary Cirrhosis Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Primary Biliary Cirrhosis Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Budesonide
Table Major Players of Budesonide
Figure Global Budesonide Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of FFP-104
Table Major Players of FFP-104
Figure Global FFP-104 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of GSK-2330672
Table Major Players of GSK-2330672
Figure Global GSK-2330672 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of MBX-8025
Table Major Players of MBX-8025
Figure Global MBX-8025 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of NGM-282
Table Major Players of NGM-282
Figure Global NGM-282 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type (2013-2018)
Table Global Primary Biliary Cirrhosis Drug Sales Share (%) by Type (2013-2018)
Figure Global Primary Biliary Cirrhosis Drug Sales Market Share (%) by Type (2013-2018)
Figure Global Primary Biliary Cirrhosis Drug Sales Market Share (%) by Type in 2017
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by Type (2013-2018)
Table Global Primary Biliary Cirrhosis Drug Revenue Share (%) by Type (2013-2018)
Figure Global Primary Biliary Cirrhosis Drug Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Type
Table Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Type (2013-2018)
Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type (2013-2018)
Table United States Primary Biliary Cirrhosis Drug Sales Share (%) by Type (2013-2018)
Figure United States Primary Biliary Cirrhosis Drug Sales Market Share (%) by Type (2013-2018)
Figure United States Primary Biliary Cirrhosis Drug Sales Market Share (%) by Type in 2017
Table United States Primary Biliary Cirrhosis Drug Revenue (Million USD) by Type (2013-2018)
Table United States Primary Biliary Cirrhosis Drug Revenue Share (%) by Type (2013-2018)
Figure United States Primary Biliary Cirrhosis Drug Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Type
Table United States Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Type (2013-2018)
Figure Clinic Examples
Figure Hospital Examples
Figure Others Examples
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application (2013-2018)
Table Global Primary Biliary Cirrhosis Drug Sales Share (%) by Application (2013-2018)
Figure Global Primary Biliary Cirrhosis Drug Sales Market Share (%) by Application (2013-2018)
Figure Global Primary Biliary Cirrhosis Drug Sales Market Share (%) by Application in 2017
Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application (2013-2018)
Table United States Primary Biliary Cirrhosis Drug Sales Share (%) by Application (2013-2018)
Figure United States Primary Biliary Cirrhosis Drug Sales Market Share (%) by Application (2013-2018)
Figure United States Primary Biliary Cirrhosis Drug Sales Market Share (%) by Application in 2017
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) by Regions (2013-2018)
Table Global Primary Biliary Cirrhosis Drug Sales Market Share (%) by Regions (2013-2018)
Figure Global Primary Biliary Cirrhosis Drug Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Primary Biliary Cirrhosis Drug Sales Market Share (%) by Regions
Figure 2017 United States Primary Biliary Cirrhosis Drug Sales Market Share (%) in Global Market
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by Regions (2013-2018)
Table Global Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Regions (2013-2018)
Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Regions
Figure 2017 United States Primary Biliary Cirrhosis Drug Revenue Market Share (%) in Global Market
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) of Key Players (2013-2018)
Table Global Primary Biliary Cirrhosis Drug Sales Share (%) by Players (2013-2018)
Figure 2017 Global Primary Biliary Cirrhosis Drug Sales Share (%) by Players
Figure 2018 Global Primary Biliary Cirrhosis Drug Sales Share (%) by Players
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by Players (2013-2018)
Table Global Primary Biliary Cirrhosis Drug Revenue Share (%) by Players (2013-2018)
Table 2017 Global Primary Biliary Cirrhosis Drug Revenue Share (%) by Players
Table 2018 Global Primary Biliary Cirrhosis Drug Revenue Share (%) by Players
Table Global Market Primary Biliary Cirrhosis Drug Average Price (USD/Pcs) by Players (2013-2018)
Table Global Primary Biliary Cirrhosis Drug Top Players Manufacturing Base Distribution and Sales Area
Table Global Primary Biliary Cirrhosis Drug Top Players Product Category
Figure Global Primary Biliary Cirrhosis Drug Market Share (%) of Top 3 Players
Figure Global Primary Biliary Cirrhosis Drug Market Share (%) of Top 5 Players
Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) by Players (2013-2018)
Table United States Primary Biliary Cirrhosis Drug Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Primary Biliary Cirrhosis Drug Sales Share (%) by Players
Figure 2018 United States Primary Biliary Cirrhosis Drug Sales Share (%) by Players
Table United States Primary Biliary Cirrhosis Drug Revenue (Million USD) by Players (2013-2018)
Table United States Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Primary Biliary Cirrhosis Drug Revenue Share (%) by Players
Table 2018 United States Primary Biliary Cirrhosis Drug Revenue Share (%) by Players
Table United States Market Primary Biliary Cirrhosis Drug Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Primary Biliary Cirrhosis Drug Market Share (%) of Top 3 Players
Figure United States Primary Biliary Cirrhosis Drug Market Share (%) of Top 5 Players
Table AlbireoPharma Basic Information List
Table AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales Growth Rate (2013-2018)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales Global Market Share (%)(2013-2018)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Revenue Global Market Share (%)(2013-2018)
Table CymaBay Therapeutics, Inc. Basic Information List
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales Growth Rate (2013-2018)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales Global Market Share (%)(2013-2018)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Revenue Global Market Share (%)(2013-2018)
Table Dr. Falk Pharma GmbH Basic Information List
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales Growth Rate (2013-2018)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales Global Market Share (%)(2013-2018)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Revenue Global Market Share (%)(2013-2018)
Table Enanta Pharmaceuticals, Inc. Basic Information List
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Growth Rate (2013-2018)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Global Market Share (%)(2013-2018)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Global Market Share (%)(2013-2018)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales Global Market Share (%)(2013-2018)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Revenue Global Market Share (%)(2013-2018)
Table Intercept Pharmaceuticals, Inc. Basic Information List
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Growth Rate (2013-2018)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Global Market Share (%)(2013-2018)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Global Market Share (%)(2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales Global Market Share (%)(2013-2018)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Revenue Global Market Share (%)(2013-2018)
Table MediGene AG Basic Information List
Table MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure MediGene AG Primary Biliary Cirrhosis Drug Sales Growth Rate (2013-2018)
Figure MediGene AG Primary Biliary Cirrhosis Drug Sales Global Market Share (%)(2013-2018)
Figure MediGene AG Primary Biliary Cirrhosis Drug Revenue Global Market Share (%)(2013-2018)
Table NGM Biopharmaceuticals, Inc. Basic Information List
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Growth Rate (2013-2018)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Global Market Share (%)(2013-2018)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Global Market Share (%)(2013-2018)
Table Virobay Inc. Basic Information List
Table Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales Growth Rate (2013-2018)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales Global Market Share (%)(2013-2018)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Revenue Global Market Share (%)(2013-2018)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Primary Biliary Cirrhosis Drug
Figure Primary Biliary Cirrhosis Drug Industrial Chain Analysis
Table Major Buyers of Primary Biliary Cirrhosis Drug
Table Distributors/Traders List
Figure Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Primary Biliary Cirrhosis DrugPrimary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Primary Biliary Cirrhosis Drug Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Primary Biliary Cirrhosis Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Primary Biliary Cirrhosis Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Primary Biliary Cirrhosis Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Primary Biliary Cirrhosis Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Primary Biliary Cirrhosis Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Primary Biliary Cirrhosis Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Primary Biliary Cirrhosis Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Primary Biliary Cirrhosis Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Primary Biliary Cirrhosis Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Primary Biliary Cirrhosis Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Primary Biliary Cirrhosis Drug Sales Forecast by Application (2018-2025)
Table United States Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Primary Biliary Cirrhosis Drug Sales Forecast by Application (2018-2025)
